For 40 minutes, participants will engage in discussions with their peers on the following suggested topics:
What will EU AI Act compliance mean in practice for medical device manufacturers?
As regulatory expectations evolve, MedTech companies need to understand how AI legislation may affect product development, validation, documentation, and market deployment.
Synthetic data in MedTech: breakthrough enabler or overestimated promise?
Synthetic datasets could unlock privacy-preserving innovation, but how reliable are they for training, testing, and clinical use?
Moving AI beyond pilots: what does it take to achieve hospital-wide adoption?
Many promising solutions stall after proof of concept. This discussion will explore the technical, organizational, and cultural challenges of scaling AI in healthcare settings.
How much explainability is enough for clinical trust?
For AI to be used confidently in real-world care, clinicians need transparency. But can systems become more interpretable without compromising performance?